Home Cart Sign in  
Chemical Structure| 117772-70-0 Chemical Structure| 117772-70-0

Structure of Azithromycin Dihydrate
CAS No.: 117772-70-0

Chemical Structure| 117772-70-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Azithromycin Dihydrate is an antibiotic for inhibition of parasite growth with IC50 of 8.4 μM.

Synonyms: CP-62993 dihydrate; Azithromycin hydrate

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Azithromycin Dihydrate

CAS No. :117772-70-0
Formula : C38H76N2O14
M.W : 785.02
SMILES Code : O=C1[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3[C@H](O)[C@@H](N(C)C)C[C@@H](C)O3)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)O1.[H]O[H].[H]O[H]
Synonyms :
CP-62993 dihydrate; Azithromycin hydrate
MDL No. :MFCD01862248

Safety of Azithromycin Dihydrate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
SW480 cells 5–225 µmol/L 24–72 hours To investigate the activation of PEPT1 transcription by DAC, results showed DAC activated PEPT1 transcription in a dose-dependent manner. PMC6029027
HCT-116 cells 5–225 µmol/L 24–72 hours To investigate the effect of CAG on HLA-A expression, results showed that CAG promoted HLA-A expression. PMC6029027
Human lung fibroblasts 10 μg/ml 24 hours Azithromycin inhibits TGFB1-induced NOX4 and myofibroblast differentiation. PMC5584851
HeLa cells 4.5 μg/ml (EC50) To evaluate the ability of BSA–RuII(CO)2 complex to release CO in HeLa cells, results showed a significant increase in intracellular fluorescence indicating CO release. PMC3163956
COS7 cells 24 hours Evaluate the inhibitory effect of compound 10a on dopamine uptake, showing a Ki value of 47 nM, which is >4 times more potent than cocaine (Ki=198 nM) PMC3163956
Neuro-2a cells 24 hours To evaluate the neurotoxicity of macrophage-conditioned media, results showed that conditioned media from azithromycin-treated macrophages significantly reduced neuronal toxicity PMC4657208
Bone marrow-derived macrophages (BMDMs) 10 or 30 μM 6 hours TsV alone induces significant production of IL-1β, demonstrating that the venom itself delivers signals necessary for inflammasome activation in BMDMs. PMC4657208
HL-1 cardiomyocytes 100μM acute exposure Azithromycin slowed beat rate, reduced phase 0 upstroke slope, and prolonged repolarization. PMC5396181
Acinetobacter baumannii (AB) 0.5 mg/L 24 hours Evaluated the bactericidal activity of azithromycin against Acinetobacter baumannii, showing significant bactericidal effects in RPMI + 5% LB media. PMC4534682
Klebsiella pneumoniae (KP) 1 mg/L 24 hours Evaluated the bactericidal activity of azithromycin against Klebsiella pneumoniae, showing significant bactericidal effects in RPMI + 5% LB media. PMC4534682
Pseudomonas aeruginosa (PA) 4 mg/L 24 hours Evaluated the bactericidal activity of azithromycin against Pseudomonas aeruginosa, showing significant bactericidal effects in RPMI + 5% LB media. PMC4534682
Beige adipocytes 5 μM 24 hours Azithromycin inhibits thermogenic and mitochondrial gene programs in beige adipocytes PMC8771569
Brown adipocytes 5 μM 24 hours Azithromycin inhibits thermogenic and mitochondrial gene programs in brown adipocytes PMC8771569

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c nude mice HCT-116 xenograft model 50 mg/kg/day Oral administration 3 consecutive days per week for 32 days Combined treatment with azithromycin and TRAIL significantly inhibited the growth of HCT-116 xenografts. The anti-tumor rate of the combined group was 45.88%. Ki-67 expression was significantly lower in the combination group than either azithromycin or TRAIL alone. PMC6029027
Mice Bleomycin-induced lung fibrosis model 150 mg/kg Intraperitoneal injection Once daily for 14 days Azithromycin attenuates bleomycin-induced lung fibrosis development by reducing NOX4 protein levels and enhancing proteasome activation. PMC5584851
Mice Conventional wild-type mice 0.1 g/L Drinking water 2 weeks Azithromycin induced a trend towards K. pneumoniae outgrowth PMC8908617
Mice M. abscessus infection model 100 mg/kg Gavage 5 days per week for 30 days Azithromycin treatment led to persistent lung infection associated with extensive granulomatous inflammation and failure of macrophage degradation of intracellular mycobacteria. PMC3163956
C57BL/6J mice Moderate-severe thoracic contusion SCI model 160 mg/kg/day Oral gavage Once daily for 3 days prior and 7 days post To evaluate the effect of azithromycin on macrophage phenotype and functional recovery after SCI, results showed that azithromycin significantly increased anti-inflammatory macrophage gene expression, decreased pro-inflammatory macrophage gene expression, and improved tissue sparing and locomotor function recovery PMC4657208
Mice Conscious mice 50mg/kg and 100mg/kg Intraperitoneal injection Single injection Azithromycin caused significant sinus slowing and increased PR, QRS, QT, and QTc intervals. PMC5396181
Mice Pneumonia model 50 or 100 mg/kg Subcutaneous injection Once every 24 hours Evaluated the therapeutic effects of azithromycin monotherapy against MDR Gram-negative bacterial infections, showing significant reduction in lung bacterial counts. PMC4534682
Mice High-fat diet-induced obesity model 50 mg/kg/day Drinking water 12 weeks Azithromycin exposure leads to increased adiposity and metabolic dysfunctions in mice under high fat diet PMC8771569

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00694694 Malaria Phase 3 Completed - Tanzania ... More >> Teule Hospital Muheza, Tanga Region, Tanzania Less <<
NCT01235546 Endometritis ... More >>Wound Infection Abscess Surgical Site Infection Less << Not Applicable Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 United States, Louisiana Ochsner Clinic Foundation New Orleans, Louisiana, United States, 70121 United States, Mississippi University of Mississippi Medical Center Jackson, Mississippi, United States, 39216 United States, New York Columbia University New York, New York, United States, 10032 United States, North Carolina Mission Hospital Asheville, North Carolina, United States, 28801 University of North Carolina Chapel Hill, North Carolina, United States, 27599-7516 United States, Texas University of Texas Medical Branch Galveston, Texas, United States, 77555-0587 University of Texas Health Science Center at Houston Houston, Texas, United States, 77225 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132 Less <<
NCT02527005 Malaria Pregn... More >>ant HIV Less << Phase 1 Completed - Nigeria ... More >> University College Hospital, Ibadan, Oyo, Nigeria, 200001 Less <<
NCT01955252 Yaws Phase 3 Completed - Papua New Guinea ... More >> Lihir Medical Centre Londolovit, New ireland province, Papua New Guinea, 034 Less <<
NCT01778634 Ureaplasma Infections Phase 2 Active, not recruiting December 2019 United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35249-7335 United States, Delaware Christiana Care Health Services Newark, Delaware, United States, 19713 United States, Maryland University of Maryland School of Medicine Baltimore, Maryland, United States, 21201 Mercy Medical Center Baltimore, Maryland, United States, 21202 Johns Hopkins University Baltimore, Maryland, United States, 21287 United States, Tennessee Monroe Carell Jr. Children's Hospital at Vanderbilt Nashville, Tennessee, United States, 37232-9544 United States, Virginia University of Virginia Charlottesville, Virginia, United States, 22908-0386 Less <<
NCT01235546 - Completed - -
NCT01382004 Yaws Treponem... More >>a Infection Neglected Tropical Disease Less << Phase 3 Completed - Papua New Guinea ... More >> Lihir Medical Centre Kavieng, New Ireland Province, Papua New Guinea, 034 Less <<
NCT02336516 Haemolytic and Uremic Syndrome Not Applicable Recruiting October 2021 France ... More >> Arnaud de Villeneuve Hospital Recruiting Montpellier, France, 34295 Montpellier cedex 5 Contact: Marc Fila, MD    +33467336428    m-fila@chu-montpellier.fr    Contact: Georges Deschenes, MD, PhD    +33140031242    georges.deschenes@rdb.aphp.fr Less <<
NCT01778634 - Active, not recruiting - -
NCT00237445 Pneumonia Phase 4 Terminated - United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less <<
NCT01227395 - Completed - -
NCT00356772 Eye Infections, Bacterial Phase 1 Completed - -
NCT03672630 Mycobacterium Avium Complex ... More >> Nontuberculous Mycobacterium Infection Less << Phase 2 Phase 3 Not yet recruiting February 28, 2023 -
NCT02960503 Sickle Cell Disease Phase 1 Phase 2 Withdrawn(Key personnel moved ... More >>to new location. Therefore, we had insufficient resources to initiate the trial.) Less << October 2018 United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37203 Less <<
NCT01178762 - Completed - -
NCT01227395 - Completed - -
NCT01178762 Chlamydial Conjunctivitis Not Applicable Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT02107274 Bronchiectasis Phase 4 Completed - Malaysia ... More >> Respiratory Unit, Taiping Hospital Taiping, Perak, Malaysia, 34000 Less <<
NCT01329588 Neisseria Gonorrhoeae Infectio... More >>n Chlamydia Trachomatis HIV Less << Phase 4 Completed - Benin ... More >> Dispensaire des infections sexuellement transmissibles Cotonou, Benin Less <<
NCT02107274 - Completed - -
NCT00649831 Bronchitis, Chronic Phase 3 Completed - France ... More >> Pfizer Investigational Site Anzin, France, 59410 Pfizer Investigational Site Avignon, France, 84 000 Pfizer Investigational Site Avignon, France, 84000 Pfizer Investigational Site Dijon, France, 21000 Pfizer Investigational Site Equeurdreville Hainneville, France, 50120 Pfizer Investigational Site Escaudain, France, 59 124 Pfizer Investigational Site Le Grand Quevilly, France, 76120 Pfizer Investigational Site Les Lilas, France, 93 260 Pfizer Investigational Site Lyon, France, 69001 Pfizer Investigational Site Mantes La Jolie, France, 78200 Pfizer Investigational Site Maromme, France, 76150 Pfizer Investigational Site Marseille, France, 13 008 Pfizer Investigational Site Maubeuge, France, 59600 Pfizer Investigational Site Mont Saint Martin, France, 54350 Pfizer Investigational Site Nancy, France, 54000 Pfizer Investigational Site Paris, France, 75 016 Pfizer Investigational Site Paris, France, 75012 Pfizer Investigational Site Paris, France, 75017 Pfizer Investigational Site Paris, France, 75020 Pfizer Investigational Site Saint Aulaire, France, 19 130 Pfizer Investigational Site Savigny, France, 91600 Pfizer Investigational Site Soissons, France, 02 200 Pfizer Investigational Site Tourcoing, France, 59200 Pfizer Investigational Site Tulette, France, 26 790 Pfizer Investigational Site Valenton, France, 94460 Pfizer Investigational Site Vaux S/ Seine, France, 78740 Pfizer Investigational Site Villejuif, France, 94800 Pfizer Investigational Site Vincennes, France, 94300 Pfizer Investigational Site Vitry, France, 94 400 Pfizer Investigational Site Wattrelos, France, 59150 Pfizer Investigational Site Yerres, France, 91330 Less <<
NCT01009619 Bronchiolitis Obliterans Syndr... More >>ome Graft Rejection Lymphocytic Bronchiolitis Respiratory Infection Less << Phase 4 Completed - Belgium ... More >> Katholieke Universiteit Leuven and University Hospital Gasthuisberg Leuven, Belgium, B-3000 Less <<
NCT03578679 Pediculoses Not Applicable Recruiting December 30, 2018 Senegal ... More >> Institut de Recherche pour le Developpement Recruiting Dakar, Senegal, 18524 Contact: Laurent Vidal, PhD    338493530 ext 221    laurent.vidal@ird.fr    Contact: Laurent Gournac, PhD    338493530 ext 221    laurent.gournac@ird.fr Less <<
NCT01103713 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT01009619 - Completed - -
NCT00286026 Trachoma Phase 4 Withdrawn(Prevalence of infect... More >>ion for screened population too low (<7%) to enroll anyone.) Less << - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 Less <<
NCT01103713 Asymptomatic Parasitemia In Pr... More >>egnancy Less << Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - Benin ... More >> Centre de Sante d'AHOUANSORI -AGUE Cotonou, Benin Hôpital Bethesda Cotonou, Benin Kenya Siaya District Hospital Siaya, Kenya Malawi Zomba Central Hospital Zomba, Malawi Tanzania Teule Hospital Muheza, Tanga, Tanzania National Institute for Medical Research (Mwanza Centre)/ Nyamagana District Hospital Mwanza, Tanzania, 1903 Uganda Mulanda Health Centre IV Kampala, Uganda Less <<
NCT00266851 Asthma Phase 3 Completed - United States, Illinois ... More >> ANSR Peoria, Illinois, United States, 61602 United States, Kansas AAFP National Research Network Kansas City, Kansas, United States, 66211 United States, Ohio RAP - Cleveland Clinic Cleveland, Ohio, United States, 44130 United States, Oklahoma University of Oklahoma Health Sciences Center (OUHSC) and Oklahoma Physicians Resource/Research Network (OKPRN) Oklahoma City, Oklahoma, United States, 73104 United States, Wisconsin Wisconsin Research and Education Network (WREN) Madison, Wisconsin, United States, 53713 Less <<
NCT00792922 Trachoma Phase 4 Completed - United States, California ... More >> UCSF Proctor Foundation San Francisco, California, United States, 94143 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21205 United Kingdom London School of Hygiene and Tropical Medicine London, United Kingdom, WC1E 7HT Less <<
NCT00347776 - Completed - -
NCT00367653 Malaria Phase 3 Completed - Burkina Faso ... More >> Pfizer Investigational Site Ouagadougou, West Africa, Burkina Faso, 01 Pfizer Investigational Site Nouna, Burkina Faso Ghana Pfizer Investigational Site Navrongo, West Africa, Ghana Kenya Pfizer Investigational Site Kisumu, Kenya, 40100 Mali Pfizer Investigational Site Bamako, West Africa, Mali Pfizer Investigational Site Bamako, Mali Senegal Pfizer Investigational Site Senegal, West Africa, Senegal Zambia Pfizer Investigational Site Ndola, Zambia Less <<
NCT00347776 Trichiasis Phase 4 Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21205 Less <<
NCT00792922 - Completed - -
NCT00796224 Acute Otitis Media Phase 2 Completed - Costa Rica ... More >> Pfizer Investigational Site San Jose, Costa Rica, 0000 Pfizer Investigational Site San Jose, Costa Rica Less <<
NCT00796224 - Completed - -
NCT00599079 Mycobacterium Avium Complex Lu... More >>ng Disease Less << Phase 4 Completed - United States, Texas ... More >> The University of Texas Health Science Center at Tyler Tyler, Texas, United States, 75708 Less <<
NCT00610623 Pneumonia, Ventilator-Associat... More >>ed Pseudomonas Infections Less << Phase 2 Terminated(The sponsor decided... More >> to stop the study prematurely because of financial issues) Less << - Belgium ... More >> Intensive Care Unit, Clinique Saint-Pierre Ottignies, Louvain, Belgium, 1340 General Intensive Car Unit, Centre Hospitalier Universitaire de Liège Liège, Belgium, B-4000 Former Serbia and Montenegro Surgical Intensive Care Unit, Clinical Center of Serbia, Institut of Neurosurgery Belgrade, Former Serbia and Montenegro Surgical Intensive Care Unit, Clinical Center of Serbia Belgrade, Former Serbia and Montenegro France Intensive Care Unit, Jean Minjoz University Hospital Besancon, France, 25030 Intensive Car Unit, Calmette University Hospital of Lille Lille, France, 59037 Medical-surgical intensive car unit, Dupuytren Teaching Hospital Limoges, France, 8700 General Intensive Care Unit, Montauban City Hospital Montauban, France, 82013 Medical Intensive Car Unit, Hospital Bichat Paris, France, 75018 Surgical Intensive Car Unit; University Hospital Bichat Paris, France, 75018 General Intensive Care Unit, Hospital Saint-Joseph Paris, France, 75674 Medical Intensive Care Unit, Cochin Hospital Paris, France, 75679 Poland Intensive Care Unit, Wojewodzki Hospital Krakow, Poland Intensive Care Unit, Wojewodzki Hospital Sosnowiec, Poland Intensive Care Unit, Central Hospital Warsaw, Poland Spain Intensive Care Unit, Hospital del Mar Barcelona, Spain, 08003 Internal Medicine, Vall d'Hebron Hospital Barcelona, Spain, 08035 Intensive Care Unit, San Dureta University Hospital Palma de Mallorca, Spain, 07014 Intensive Care Unit, Joan XXIII University Hospital Tarragona, Spain, 43007 Switzerland Surgical and Medical Intensive Care Units, University Hospital Lausanne Lausanne, Vaud, Switzerland Less <<
NCT01154569 Bariatric Surgery Not Applicable Completed - Canada, Alberta ... More >> University of Alberta Hospital Edmonton, Alberta, Canada, T6G2B7 Less <<
NCT01202331 Trachoma Chla... More >>mydia Less << Phase 4 Completed - Ethiopia ... More >> The Carter Center, Ethiopia Addis Ababa, Ethiopia Less <<
NCT01270074 Cystic Fibrosis ... More >> Bronchiectasis Less << Phase 3 Recruiting December 2020 Australia, New South Wales ... More >> Sydney Children's Hospital Recruiting Sydney, New South Wales, Australia Principal Investigator: Adam Jaffe, FRACP          Westmead Children's Hospital Recruiting Sydney, New South Wales, Australia Principal Investigator: Peter Cooper, FRACP          Australia, Queensland Mater Children's Hospital Recruiting Brisbane, Queensland, Australia Principal Investigator: Carolyn Dakin, FRACP          Royal Children's Hospital Recruiting Brisbane, Queensland, Australia Principal Investigator: Claire Wainwright, FRACP          Australia, South Australia Women's and Children's Hospital Recruiting Adelaide, South Australia, Australia Principal Investigator: Andrew Tai, FRACP          Australia, Victoria Monash Medical Centre Recruiting Melbourne, Victoria, Australia Principal Investigator: David Armstrong, FRACP          Royal Children's Hospital Recruiting Melbourne, Victoria, Australia Contact: Philip J Robinson, MD PhD Fracp       phil.robinson@rch.org.au    Principal Investigator: Philip J Robinson, MD PhD FRACP          Australia, Western Australia Princess Margaret Hospital for Children Recruiting Perth, Western Australia, Australia, 6008 Principal Investigator: Barry S Clements, MBBS          New Zealand Starship Hospital Recruiting Auckland, New Zealand Principal Investigator: Cass Byrnes, FRACP          Christchurch Hospital Not yet recruiting Christchurch, New Zealand Principal Investigator: Philip Pattemore, FRACP Less <<
NCT01327625 Graft vs Host Disease ... More >> Bronchiolitis Obliterans Less << Not Applicable Terminated(Preliminary reports... More >> of this study was too bad.) Less << - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT01767506 - Completed - -
NCT01617083 PANS PANDAS ... More >> Obsessive Compulsive Disorder (OCD) Less << Phase 2 Completed - United States, Florida ... More >> Rothman Center for Neuropsychiatry Saint Petersburg, Florida, United States, 33701 Less <<
NCT01531218 Diarrhea Feve... More >>r Vomiting Abdominal Pain Less << Phase 3 Completed - Denmark ... More >> Department of Infectious Diseases, Aalborg Hospital Aalborg, Denmark, 9000 Less <<
NCT01919996 Pharyngitis T... More >>onsillitis Less << Phase 2 Terminated(See Termination Sta... More >>tement in the Detailed Description below) Less << - United States, California ... More >> Martel Eye Medical Group Rancho Cordova, California, United States, 95670 United States, Illinois Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States, 60611 Outpatient Center in Lincoln Park Chicago, Illinois, United States, 60614 Infant Welfare Society of Chicago Chicago, Illinois, United States, 60647 United States, Utah Murray Pediatrics Murray, Utah, United States, 84107 Daynes Eye and Lasik Salt Lake City, Utah, United States, 84124 Less <<
NCT01767506 Trachoma Not Applicable Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21205 Less <<
NCT01617083 - Completed - -
NCT01783340 Malaria, Falciparum Phase 1 Phase 2 Withdrawn(No funding) April 2014 Netherlands ... More >> Leiden University Medical Centre Leiden, Netherlands, 2333ZA Less <<
NCT02048007 Childhood Mortality Phase 4 Enrolling by invitation December 2019 United States, California ... More >> UCSF Proctor Foundation San Francisco, California, United States, 94143-0944 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21205 Malawi College of Medicine at the University of Malawi, Blantyre Blantyre, Malawi Niger The Carter Center, Niger Niamey, Niger Tanzania Kongwa Trachoma Project Kongwa, Tanzania United Kingdom London School of Hygiene & Tropical Medicine London, United Kingdom Less <<
NCT02047981 Childhood Mortality Phase 4 Completed - United States, California ... More >> UCSF Proctor Foundation San Francisco, California, United States, 94143 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21205 Malawi College of Medicine at the University of Malawi, Blantyre Blantyre, Malawi Niger The Carter Center, Niger Niamey, Niger Tanzania Kongwa Trachoma Project Kongwa, Tanzania United Kingdom London School of Hygiene & Tropical Medicine London, United Kingdom Less <<
NCT01919996 - Terminated(See Termination Sta... More >>tement in the Detailed Description below) Less << - -
NCT02176057 Trachoma Phase 2 Phase 3 Withdrawn(Nepal Ministry of He... More >>alth implemented public drug treatment prior to the proposed start date) Less << - Nepal ... More >> Geta Eye Hospital Geta, Kailali, Nepal, 10900 Less <<
NCT02196493 Chronic Cough Phase 3 Unknown December 2016 United Kingdom ... More >> Respiratory Research Unit Recruiting Nottingham, Nottinghamshire, United Kingdom, NG5 1PB Contact: Matthew Martin, MBChB    01158231935       Principal Investigator: Tim Harrison, MD, FRCP          Sub-Investigator: Matthew Martin, MBChB MRCP Less <<
NCT02414399 Pneumonia Dia... More >>rrhea Malaria Co-infection Death Malnutrition Less << Phase 4 Recruiting December 2020 Kenya ... More >> Kisii Teaching and Referral Hospital, Homa Bay District Hospital, St. Paul's Mission Hospital Recruiting Kisii And Homa Bay Counties, Kenya Contact: Benson Singa, MBChB, MPH       singabo2008@gmail.com Less <<
NCT02677701 Cystic Fibrosis Phase 4 Recruiting March 31, 2020 -
NCT03523156 Trachoma Phase 4 Not yet recruiting December 2020 Ethiopia ... More >> Not yet recruiting Amhara, Ethiopia Contact: Demelash Gessesse    251 920 258 272       Contact: Zerihun Tadesse    251-91-140-1498    Zerihun.Tadesse@cartercenter.org Less <<
NCT01464840 - Completed - -
NCT03045198 Cystic Fibrosis Phase 4 Enrolling by invitation December 2018 -
NCT03338244 Childhood Mortality Phase 4 Recruiting July 31, 2019 United States, California ... More >> UCSF Proctor Foundation Active, not recruiting San Francisco, California, United States, 94143-0944 Niger The Carter Center Recruiting Niamey, Niger Contact: Mohamed Salissou Kane, PhD    +227 20 73 28 57    mohamedsalissoukane@yahoo.fr Less <<
NCT03335072 Trachoma Phase 4 Not yet recruiting July 1, 2022 United States, California ... More >> UCSF Proctor Foundation Active, not recruiting San Francisco, California, United States, 94143 Ethiopia The Carter Center Not yet recruiting Addis Ababa, Ethiopia Contact: Zerihun Tadesse, MD    +251-116-631863    Zerihun.Tadesse@ucsf.edu Less <<
NCT02557958 Chronic Obstructive Pulmonary ... More >>Disease Less << Early Phase 1 Active, not recruiting December 2020 -
NCT03568643 Uncomplicated Severe Acute Mal... More >>nutrition Less << Phase 4 Not yet recruiting May 2020 -
NCT02630394 Sickle Cell Disease ... More >> Acute Chest Syndrome Less << Phase 1 Withdrawn(Principal Investigat... More >>or has moved to another institution) Less << - United States, Mississippi ... More >> University of Mississippi Medical Center Jackson, Mississippi, United States, 39216 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States Less <<
NCT03736629 Asthma Chronic Phase 2 Not yet recruiting February 2020 United States, Illinois ... More >> Northwestern University Not yet recruiting Chicago, Illinois, United States, 60201 Contact: Lew Smith, MD          University of Chicago Not yet recruiting Chicago, Illinois, United States, 60637 Contact: Steve White, MD Less <<
NCT03187834 Child Development Phase 4 Active, not recruiting September 1, 2019 United States, California ... More >> UCSF Proctor Foundation San Francisco, California, United States, 94143 Burkina Faso Centre de Recherche en Santé de Nouna Nouna, Burkina Faso Less <<
NCT01602055 Fasting Phase 1 Completed - Indonesia ... More >> PT Clinisindo Laboratories Jakarta, Indonesia Less <<
NCT01008761 Asthma Not Applicable Unknown December 2013 Canada, Alberta ... More >> Alberta Children's Hospital Recruiting Calgary, Alberta, Canada, T3B 6A8 Contact: Janielee Williamson, RN    403-955-3186    janie.williamson@albertahealthservices.ca    Contact: Paula Finnson    403-955-7873    paula.finnson@albertahealthservices.ca    Principal Investigator: David Johnson, MD          Sub-Investigator: Sheldon Spier, MD          Sub-Investigator: James D Kellner, MD          Sub-Investigator: Candice Bjornson, MD          Sub-Investigator: Michael Surrette, PhD          Sub-Investigator: Alberto Nettle-Aguire, PhD          Stollery Children's Hospital Recruiting Edmonton, Alberta, Canada, T6G 2V7 Contact: Piush Mandhane, MD       piush.mandhane@albertahealthservices.ca    Principal Investigator: Piush Mandhane, MD          Sub-Investigator: William Craig, MD          Sub-Investigator: Darryl Adamko, MD          Sub-Investigator: Bonita Lee, MD          Sub-Investigator: Carina Majaesic, MD Less <<
NCT01586169 Parasitic Diseases ... More >> Bacterial Diseases Less << Not Applicable Completed - Mali ... More >> Centre National D'Appui a la lutte contre la Maladie Bamako, Mali Less <<
NCT01915082 Disorder Related to Lung Trans... More >>plantation Less << Phase 4 Completed - Belgium ... More >> University Hospitals Leuven Leuven, Belgium, B-3000 Less <<
NCT01464840 - Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35249 Less <<
NCT00643539 Tonsillitis Phase 4 Completed - France ... More >> Pfizer Investigational Site Ancenis, France, 44150 Pfizer Investigational Site Asnieres Sur Seine, France, 92600 Pfizer Investigational Site Auch, France, 32000 Pfizer Investigational Site Boulogne, France, 92100 Pfizer Investigational Site Brest, France, 29200 Pfizer Investigational Site Brive, France, 19100 Pfizer Investigational Site Cannes La Boca, France, 06150 Pfizer Investigational Site Chalons En Champagne, France, 51000 Pfizer Investigational Site Chambery, France, 73000 Pfizer Investigational Site Champigny sur Marne, France, 94500 Pfizer Investigational Site Combs La Ville, France, 77380 Pfizer Investigational Site Dijon, France, 21000 Pfizer Investigational Site Draguignan, France, 33170 Pfizer Investigational Site Draguignan, France, 83300 Pfizer Investigational Site Essey Les Nancy, France, 54270 Pfizer Investigational Site Lagny, France, 77400 Pfizer Investigational Site Les Sables D`olonne, France, 85100 Pfizer Investigational Site Les Ulis, France, 91940 Pfizer Investigational Site Levallois Perret, France, 92300 Pfizer Investigational Site Marseille, France, 13006 Pfizer Investigational Site Marseille, France, 13013 Pfizer Investigational Site Marseille, France, 13014 Pfizer Investigational Site Massy, France, 91300 Pfizer Investigational Site Meudon La Foret, France, 92360 Pfizer Investigational Site Meysieu, France, 69330 Pfizer Investigational Site Millery, France, 69390 Pfizer Investigational Site Nogent Sur Marne, France, 94130 Pfizer Investigational Site Paris, France, 75004 Pfizer Investigational Site Paris, France, 75005 Pfizer Investigational Site Paris, France, 75015 Pfizer Investigational Site Paris, France, 75019 Pfizer Investigational Site Paris, France, 75020 Pfizer Investigational Site Saint Marcel, France, 71380 Pfizer Investigational Site Saint Quentin, France, 02100 Pfizer Investigational Site Salon de Provence, France, 13300 Pfizer Investigational Site Sartrouville, France, 78500 Pfizer Investigational Site Selestat, France, 67600 Pfizer Investigational Site Strasbourg, France, 67100 Pfizer Investigational Site Thionville, France, 57100 Pfizer Investigational Site Tours, France, 37000 Pfizer Investigational Site Tresses, France, 33370 Pfizer Investigational Site Vandoeuvre Les Nancy, France, 54500 Pfizer Investigational Site Varois Et Chaignot, France, 21490 Pfizer Investigational Site Vence, France, 06140 Pfizer Investigational Site Versailles, France, 78000 Less <<
NCT02307825 Chronic Rhinosinusitis ... More >> High-risk Patient Less << Phase 4 Completed - Canada, Quebec ... More >> Centre Hospitalier de l'Université de Montréal (CHUM) Montreal, Quebec, Canada, H2W 1T8 Less <<
NCT03682640 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus Metabolic Disease Glucose Metabolism Disorders Endocrine System Diseases Juvenile Diabetes Insulin Dependent Diabetes Type 1 Diabetes Mellitus Inflammation Diet Modification Less << Phase 2 Recruiting December 31, 2021 Sweden ... More >> The Queen Silvia Children's Hospital / Sahlgrenska University Hospital Recruiting Gothenburg, Sweden Contact: Gun Forsander Less <<
NCT01071161 Cough Chronic... More >> Obstructive Pulmonary Disease Chronic Bronchitis Less << Phase 3 Completed - Netherlands ... More >> Isala Klinieken Zwolle, Ov, Netherlands, 8011 JW Less <<
NCT01667692 Peptic Ulcer ... More >>Dyspepsia H-pylori Less << Phase 4 Completed - Iran, Islamic Republic of ... More >> Behnam Baghianimoghadam Yazd, Iran, Islamic Republic of, 8916863411 Less <<
NCT00431964 - Completed - -
NCT02972957 Influenza Phase 4 Recruiting December 2019 Gambia ... More >> Medical Research Council unit The Gambia Recruiting Banjul, Gambia Contact: Thushan de Silva, FRCP    +220-4495442    tdesilva@mrc.gm Less <<
NCT00431964 Cystic Fibrosis Phase 4 Completed - -
NCT03090048 Acne Vulgaris Early Phase 1 Not yet recruiting May 31, 2019 Canada, British Columbia ... More >> Manchanda Mc Not yet recruiting Surrey, British Columbia, Canada, V3W2T2 Contact: VINOD TAWAR, MD    604 754 2235    TAWAR.VINOD@YAHOO.COM Less <<
NCT01444469 Asthma Phase 4 Completed - United Kingdom ... More >> Barnsley Hospital NHS Foundation Barnsley, England, United Kingdom, S75 2EP Countess of Chester Hospital NHS Foundation Trust Liverpool, England, United Kingdom, CH2 1UL Surrey & Sussex Healthcare NHS Trust Surrey, England, United Kingdom, RH1 5RH Heart of England NHS Foundation Trust Birmingham, United Kingdom, B9 5SS Blackpool Teaching Hospitals NHS Foundation Trust Blackpool, United Kingdom, FY3 8NR University of Glasgow Glasgow, United Kingdom, G12 0YN University Hospitals of Leicester NHS Foundation Trust Leicester, United Kingdom, LE39QP Imperial College Healthcare NHS Trust London, United Kingdom, W2 1PG University Hospital of South Manchester Foundation Trust Manchester, United Kingdom, M23 9QZ Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle, United Kingdom, NE7 7DN Nottingham University Hospitals NHS Trust Nottingham, United Kingdom, NG5 1PB Portsmouth Hospitals NHS Trust Portsmouth, United Kingdom, PO6 3LY University Hospital of North Tees Stockton-on-Tees, United Kingdom, TS19 8PE Sherwood Forest Hospitals NHS Foundation Trust Sutton in Ashfield, United Kingdom, NG17 4JL Less <<
NCT02288832 Low Risk of Preterm Delivery Phase 2 Phase 3 Completed - France ... More >> Assistance Publique Hopitaux de Marseille Marseille, France, 13354 Hôpital Nord Assistance Publique Hôpitaux de Marseille Marseille, France, 13915 Less <<
NCT00682656 Cutaneous Leishmaniasis Phase 2 Phase 3 Terminated(Efficacy issues on ... More >>test arm) Less << - Brazil ... More >> Núcleo de Medicina Tropical University of Brasília - Health Center Corte de Pedras Presidente Tancredo Neves, Bahia, Brazil, 45416-000 University Estadual de Montes Claros Montes Claros, MG, Brazil, 39401-002 Centro de Pesquisas René Rachou - Fiocruz Belo Horizonte, Minas Gerais, Brazil, 30190-002 Less <<
NCT00137007 Pneumonia Phase 4 Completed - -
NCT00879983 Healthy Volunteers Phase 1 Completed - China ... More >> Pfizer Investigational Site Shanghai, China, 200040 Less <<
NCT00939185 - Completed - -
NCT03235141 Bacterial Conjunctivitis Phase 1 Recruiting December 30, 2017 China, Beijing ... More >> Beijing Tongren Hospital Recruiting Beijing, Beijing, China, 100005 Contact: Feng Wu    010-58268422    trdrug@126.com Less <<
NCT00830206 Healthy Phase 1 Completed - United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less <<
NCT00939185 - Completed - -
NCT00035347 Community-Acquired Pneumonia (... More >>CAP) Less << Phase 4 Completed - -
NCT01102244 Blepharitis Phase 3 Completed - United States, Massachusetts ... More >> Ora Andover, Massachusetts, United States, 01810 Less <<
NCT00830206 - Completed - -
NCT01109160 Lymphocytic Bronchi(Oli)Tis Po... More >>st-lung Transplantation Less << PHASE4 COMPLETED 2025-07-13 University Hospital Gasthuisbe... More >>rg, Leuven, Vlaams-Brabant, B-3000, Belgium Less <<
NCT00834756 Healthy Phase 1 Completed - United States, Missouri ... More >> Gateway Medical Research, Inc. St. Charles, Missouri, United States, 63301 Less <<
NCT00834756 - Completed - -
NCT00875966 Infections Phase 1 Completed - -
NCT00834132 - Completed - -
NCT00834132 Healthy Phase 1 Completed - United States, Missouri ... More >> Gateway Medical Research, Inc. St. Charles, Missouri, United States, 63301 Less <<
NCT00578955 Blepharoconjunctivitis Phase 3 Completed - -
NCT00754949 Blepharoconjunctivitis Phase 3 Withdrawn - -
NCT00367120 Sinusitis Phase 4 Completed - -
NCT00830336 Healthy Phase 1 Completed - United States, North Dakota ... More >> PRACS Institute Ltd. Fargo, North Dakota, United States, 58104 Less <<
NCT00644774 Healthy Phase 4 Completed - United States, Arizona ... More >> Scottsdale, Arizona, United States, 85251 United States, Florida St. Petersburg, Florida, United States, 33710 United States, Ohio Miamiville, Ohio, United States, 45147 Less <<
NCT00564447 Bacterial Infections ... More >> Eye Infections Less << Phase 4 Completed - -
NCT00830336 - Completed - -
NCT00865670 Infection Phase 1 Completed - -
NCT00360100 Otitis Media Phase 3 Completed - United States, Kentucky ... More >> Pfizer Investigational Site Bardstown, Kentucky, United States Pfizer Investigational Site Springfield, Kentucky, United States Argentina Pfizer Investigational Site Cordoba, Argentina Chile Pfizer Investigational Site Santiago, RM, Chile Pfizer Investigational Site Independencia, Santiago, Chile Pfizer Investigational Site Providencia, Santiago, Chile Costa Rica Pfizer Investigational Site San Jose, Costa Rica Dominican Republic Pfizer Investigational Site Santo Domingo, DN, Dominican Republic Guatemala Pfizer Investigational Site Ciudad Guatemala, Guatemala Pfizer Investigational Site Guatemala, Guatemala Panama Pfizer Investigational Site Ciudad de Panama, Panama Less <<
NCT00629980 Blepharitis Phase 4 Completed - United States, California ... More >> Sall Research Medical Center Artesia, California, United States, 90701 North Valley Eye Medical Group Mission Hills, California, United States, 91345 United States, Florida Center for Excellence in Eye Care Miami, Florida, United States, 33176 United States, Kentucky Kentuckiana Institute for Eye Research Louisville, Kentucky, United States, 40207 United States, Missouri Tauber Eye Center Kansas City, Missouri, United States, 64111 Silverstein Eye Centers Kansas City, Missouri, United States, 64133 United States, New York South Shore Eye Care, LLP Wantagh, New York, United States, 11793 United States, Tennessee Toyos Clinic Jackson, Tennessee, United States, 38301 United States, Texas Corona Research Consultants, Inc. El Paso, Texas, United States, 79904 Less <<
NCT00649935 Healthy Phase 1 Completed - United States, West Virginia ... More >> Kendle International Inc. Morgantown, West Virginia, United States, 26505 Less <<
NCT01408082 Blepharitis Phase 3 Completed - -
NCT00998309 - Completed - -
NCT00564447 - Completed - -
NCT00105469 - Completed - -
NCT00650273 Healthy Phase 1 Completed - United States, West Virginia ... More >> Kendle International Inc. Morgantown, West Virginia, United States, 26505 Less <<
NCT00998309 - Completed - -
NCT00105534 Bacterial Conjunctivitis Phase 3 Completed - -
NCT00629941 Blepharitis Phase 4 Completed - United States, Maine ... More >> Central Maine Eye Care Lewiston, Maine, United States, 04240 United States, Massachusetts Ophthalmic Research Associates Andover, Massachusetts, United States, 01810 Less <<
NCT00105534 - Completed - -
NCT00656539 Blepharitis Phase 4 Completed - United States, New York ... More >> Ophthalmic Consultants of Long Island Lynbrook, New York, United States, 11563 Less <<
NCT00105469 Bacterial Conjunctivitis Phase 3 Completed - -
NCT00575367 Bacterial Infections ... More >> Eye Infections Less << Phase 4 Completed - United States, New York ... More >> Mount Sinai School of Medicine New York, New York, United States, 10029 Less <<
NCT00575380 - Completed - -
NCT00629590 Blepharitis Phase 4 Completed - United States, New York ... More >> South Shore Eye Care Wantagh, New York, United States, 11793 Less <<
NCT01797107 Meibomian Gland Dysfunction Phase 2 Withdrawn(Lack of enrollment) - United States, Pennsylvania ... More >> Philadelphia Eye Associates Philadelphia, Pennsylvania, United States, 19148 Less <<
NCT00575380 Bacterial Infections ... More >> Eye Infections Cataract Extraction Less << Phase 4 Completed - United States, Arizona ... More >> Cornea Consultants of Arizone Phoenix, Arizona, United States, 85032 United States, Arkansas Eye Care Arkansas Little Rock, Arkansas, United States, 72205 United States, California North Valley Eye Medical Group Mission Hills, California, United States, 91345 United States, Florida Center for Excellence in Eye Care Miami, Florida, United States, 33176 Eye Center of North Florida Panama City, Florida, United States, 32405 United States, Georgia Coastal Research Associates, LLC Atlanta, Georgia, United States, 30339 United States, Kentucky Kentuckiana Institute for Eye Research Louisville, Kentucky, United States, 40207 United States, Missouri Ophthalmology Associates St. Louis, Missouri, United States, 63131 United States, New York Ophthalmic Consultants of Long Island Rockville Centre, New York, United States, 11563 United States, Pennsylvania Eye Care Specialists Kingston, Pennsylvania, United States, 18704 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29464 Glaucoma Consultants and Center for Eye Research Mount Pleasant, South Carolina, United States, 29464 United States, Texas Corona Research Consultants El Paso, Texas, United States, 79904 Less <<
NCT00575367 - Completed - -
NCT00866216 Infection Phase 1 Completed - -
NCT05437783 Comparative Bioavailability St... More >>udy Less << PHASE1 UNKNOWN 2022-07-01 Bangabandhu Sheikh Mujib Medic... More >>al University, Dhaka, 1205, Bangladesh Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.27mL

0.25mL

0.13mL

6.37mL

1.27mL

0.64mL

12.74mL

2.55mL

1.27mL

References

 

Historical Records

Categories